Revenues

6 Months Ended

Jun. 30, 2022

Revenues

Revenues

Note 3.     Revenues

Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
JAKAFI revenues, net	$	597,673	$	529,055	$	1,142,137	$	994,765
ICLUSIG revenues, net		26,224		28,189		52,293		53,834
PEMAZYRE revenues, net		18,983		17,906		37,015		31,362
MINJUVI revenues, net		4,411		—		8,913		—
OPZELURA revenues, net		16,560		—		29,314		—
Total product revenues, net		663,851		575,150		1,269,672		1,079,961
JAKAVI product royalty revenues		83,711		82,038		154,578		147,640
OLUMIANT product royalty revenues		30,254		36,045		78,318		68,303
TABRECTA product royalty revenues		3,581		2,476		7,064		4,523
Total product royalty revenues		117,546		120,559		239,960		220,466
Milestone and contract revenues		130,000		10,000		135,000		10,000
Total revenues	$	911,397	$	705,709	$	1,644,632	$	1,310,427

For further information on our revenue-generating contracts, refer to Note 7.